|
| 易明医药(002826)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2027-04-26 | 18.00 | 0.09% | 18627.93 | 439.84 | 18297.93 | 95.96% | 股权激励限售股份 | | 2027-03-10 | 140.00 | 0.73% | 18609.93 | 457.84 | 18297.93 | 95.96% | 股权激励限售股份 | | 2027-01-07 | 172.00 | 0.90% | 18469.93 | 597.84 | 18297.93 | 95.96% | 股权激励限售股份 | | 2022-11-30 | 47.21 | 0.25% | 17620.46 | 1447.76 | 17620.46 | 92.41% | 股权激励限售股份 | | 2021-11-26 | 48.56 | 0.25% | 11956.21 | 7162.83 | 11956.21 | 62.54% | 股权激励限售股份 | | 2021-11-12 | 49.01 | 0.26% | 18972.00 | 147.04 | 19119.04 | 100.00% | 股权激励限售流通 | | 2019-12-09 | 5803.47 | 30.04% | 18972.00 | 349.00 | 19321.00 | 100.00% | 发行前股份限售流通 | | 2017-12-11 | 8425.53 | 44.41% | 13168.53 | 5803.47 | 18972.00 | 100.00% | 发行前股份限售流通 |
|